MARKET

ENSC

ENSC

Ensysce Biosciences Inc
NASDAQ
0.2892
+0.0120
+4.33%
Opening 11:11 05/15 EDT
OPEN
0.2766
PREV CLOSE
0.2772
HIGH
0.2900
LOW
0.2541
VOLUME
560.76K
TURNOVER
--
52 WEEK HIGH
2.750
52 WEEK LOW
0.2300
MARKET CAP
2.68M
P/E (TTM)
-0.0727
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 2d ago
Ensysce announces expansion of patent protection for MPAR technology
TipRanks · 3d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 3d ago
Ensysce Biosciences Announces Receipt Of A Patent For Its Multi-Pill Abuse Resistance Technology From The Taiwan Intellectual Property Office
Benzinga · 3d ago
Ensysce says Taiwan grants MPAR overdose-protection patent through 2042
PUBT · 3d ago
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 3d ago
Weekly Report: what happened at ENSC last week (0504-0508)?
Weekly Report · 4d ago
Ensysce CEO speaks at Pain Therapeutics Summit Europe in Amsterdam
PUBT · 05/08 12:00
More
About ENSC
Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical company. The Company develops solutions for severe pain relief while reducing the potential for opioid misuse, abuse, and overdose. Its pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection (TAAP) platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant (MPAR) platform. Its lead product, PF614, is a TAAP extended-release oxycodone and a potential analgesic to treat severe pain. Its second product, PF614-MPAR, is to treat severe pain with the added benefit of oral overdose protection, is a combination product of the TAAP prodrug PF614 with a trypsin inhibitor. Additionally, nafamostat, which is an ingredient in its overdose protection combination products, is also being developed for the intended purpose of treating infection and pulmonary lung diseases.

Webull offers Ensysce Biosciences Inc stock information, including NASDAQ: ENSC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENSC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ENSC stock methods without spending real money on the virtual paper trading platform.